Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric Surgery

NCT03391401 is registered in ClinicalTrials.gov with St. Franziskus Hospital as lead sponsor.

NCT NCT03391401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03391401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric Surgery
Lead sponsor
St. Franziskus Hospital
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
July 31, 2021
Enrollment
204 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bariatric surgery candidate, microbiome, nafld, obesity, morbid